StockData
Serina Therapeutics, Inc. logo

Serina Therapeutics, Inc. (SER) stock

SERNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.20−0.15 (-11.11%)

Close on Nov 19, 2026Market cap $30.48MP/E –Yield –

Serina Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Serina Therapeutics's price to book ratio was 19.5× on Jan 30, 2026, against 14.3× a year earlier. Over the last 3 years it ranged from 8.7× to 92.8×, with a median of 19.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 202619.5×+8.0
2025Dec 31, 202511.5×−2.9
2020Apr 30, 202014.3×−1.5
2019Dec 31, 201915.8×+1.9
2018Dec 31, 201813.9×–

More Serina Therapeutics figures

See a number that looks wrong?